Reverse Transcriptase Inhibitors in HIV/AIDS Therapy
Despite significant pharmacological advances, the backbone of the most highly active antiretroviral therapy regimens for controlling HIV/AIDS is still a combination of reverse transcriptase inhibitors (RTIs) first discovered in the late 1980s. In Reverse Transcriptase Inhibitors in HIV/AIDS Therapy,...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Totowa, NJ :
Humana Press,
2006.
|
Σειρά: | Infectious Disease
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Structural Studies on HIV Reverse Transcriptase Related to Drug Discovery
- Zidovudine, Lamivudine, and Abacavir
- Stavudine, Didanosine, and Zalcitabine
- Emtricitabine
- Nucleotide Analogs
- Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
- Pharmacokinetics of Reverse Transcriptase Inhibitors
- Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy
- Mitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy
- Mitochondrial Toxicity and Lipodystrophy
- Nevirapine
- Efavirenz
- Delavirdine
- Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors
- Vertical Transmission of HIV and Therapeutic Interventions
- New Reverse Transcriptase Inhibitors in Development
- Antiretroviral Drugs for Millions.